Breaking News: The Covid-19 treatment remdesivir has no substantial effect on a patient’s chances of survival, a clinical trial by the World Health Organization has found on.ft.com/319YsKh 
Results from the WHO’s highly anticipated Solidarity trial found that none of the treatments ‘substantially affected mortality’ or reduced the need to ventilate patients, according to a copy of the study seen by the FT on.ft.com/2H5OClH
Remdesivir was one of a series of drugs used to treat US President Donald Trump after he tested positive for Covid-19. It was developed by US drugmaker Gilead Sciences, who suggested that the treatment may reduce the likelihood of death on.ft.com/2H5OClH
‘The emerging data appear inconsistent with more robust evidence from multiple randomised, controlled studies validating the clinical benefit of [remdesivir],’ Gilead said in response to the trial’s findings on.ft.com/2H5OClH
The WHO’s findings mean that the only drug proven to increase Covid-19 survival rates is dexamethasone, a cheap steroid that can be taken orally and is widely available around the world on.ft.com/2H5OClH
• • •
Missing some Tweet in this thread? You can try to
force a refresh
